Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Pegylated recombinant human factor IX

EU orphan designation number: EU/3/09/640
Active ingredient: Pegylated recombinant human factor IX
Indication: Treatment of haemophilia B
Sponsor: Novo Nordisk A/S
Novo Allé, 2880 Bagsvaerd, Danmark

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
20/05/2009 Orphan designation EMEA/OD/005/09 (2009)4058 of 15/05/2009
05/05/2017 Removal of orphan designation from Community Register